ILMN Quote, Financials, Valuation and Earnings

Labcorp Holdings, Inc. has a net margin of 28.79% compared to Illumina, Inc.'s net margin of 4.69%. Illumina, Inc.'s return on equity of 35.12% beat Labcorp Holdings, Inc.'s return on equity of 10.39%.

Illumina, Inc. has a consensus price target of $136.11, signalling upside risk potential of 6.85%. On the other hand Labcorp Holdings, Inc. has an analysts' consensus of $308.29 which suggests that it could grow by 12.63%. Given that Labcorp Holdings, Inc. has higher upside potential than Illumina, Inc., analysts believe Labcorp Holdings, Inc. is more attractive than Illumina, Inc..

Illumina, Inc. has a beta of 1.490, which suggesting that the stock is 49.007% more volatile than S&P 500. In comparison Labcorp Holdings, Inc. has a beta of 1.017, suggesting its more volatile than the S&P 500 by 1.691%.

Illumina, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Labcorp Holdings, Inc. offers a yield of 1.05% to investors and pays a quarterly dividend of $0.72 per share. Illumina, Inc. pays -- of its earnings as a dividend. Labcorp Holdings, Inc. pays out 27.54% of its earnings as a dividend. Labcorp Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Illumina, Inc. quarterly revenues are $1.2B, which are smaller than Labcorp Holdings, Inc. quarterly revenues of $3.5B. Illumina, Inc.'s net income of $334M is higher than Labcorp Holdings, Inc.'s net income of $164.9M. Notably, Illumina, Inc.'s price-to-earnings ratio is 23.31x while Labcorp Holdings, Inc.'s PE ratio is 26.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina, Inc. is 4.58x versus 1.65x for Labcorp Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Mettler-Toledo International, Inc. has a net margin of 28.79% compared to Illumina, Inc.'s net margin of 25.3%. Illumina, Inc.'s return on equity of 35.12% beat Mettler-Toledo International, Inc.'s return on equity of --.

Illumina, Inc. has a consensus price target of $136.11, signalling upside risk potential of 6.85%. On the other hand Mettler-Toledo International, Inc. has an analysts' consensus of $1,505.23 which suggests that it could grow by 19.47%. Given that Mettler-Toledo International, Inc. has higher upside potential than Illumina, Inc., analysts believe Mettler-Toledo International, Inc. is more attractive than Illumina, Inc..

Illumina, Inc. has a beta of 1.490, which suggesting that the stock is 49.007% more volatile than S&P 500. In comparison Mettler-Toledo International, Inc. has a beta of 1.433, suggesting its more volatile than the S&P 500 by 43.324%.

Illumina, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Mettler-Toledo International, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Illumina, Inc. pays -- of its earnings as a dividend. Mettler-Toledo International, Inc. pays out -- of its earnings as a dividend.

Illumina, Inc. quarterly revenues are $1.2B, which are larger than Mettler-Toledo International, Inc. quarterly revenues of $1.1B. Illumina, Inc.'s net income of $334M is higher than Mettler-Toledo International, Inc.'s net income of $285.8M. Notably, Illumina, Inc.'s price-to-earnings ratio is 23.31x while Mettler-Toledo International, Inc.'s PE ratio is 29.59x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina, Inc. is 4.58x versus 6.40x for Mettler-Toledo International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Natera, Inc. has a net margin of 28.79% compared to Illumina, Inc.'s net margin of 7.1%. Illumina, Inc.'s return on equity of 35.12% beat Natera, Inc.'s return on equity of -15.66%.

Illumina, Inc. has a consensus price target of $136.11, signalling upside risk potential of 6.85%. On the other hand Natera, Inc. has an analysts' consensus of $259.11 which suggests that it could grow by 24.58%. Given that Natera, Inc. has higher upside potential than Illumina, Inc., analysts believe Natera, Inc. is more attractive than Illumina, Inc..

Illumina, Inc. has a beta of 1.490, which suggesting that the stock is 49.007% more volatile than S&P 500. In comparison Natera, Inc. has a beta of 1.683, suggesting its more volatile than the S&P 500 by 68.297%.

Illumina, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Natera, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Illumina, Inc. pays -- of its earnings as a dividend. Natera, Inc. pays out -- of its earnings as a dividend.

Illumina, Inc. quarterly revenues are $1.2B, which are larger than Natera, Inc. quarterly revenues of $665.5M. Illumina, Inc.'s net income of $334M is higher than Natera, Inc.'s net income of $47.3M. Notably, Illumina, Inc.'s price-to-earnings ratio is 23.31x while Natera, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina, Inc. is 4.58x versus 12.66x for Natera, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

GeneDx Holdings Corp. has a net margin of 28.79% compared to Illumina, Inc.'s net margin of -14.6%. Illumina, Inc.'s return on equity of 35.12% beat GeneDx Holdings Corp.'s return on equity of -7.62%.

Illumina, Inc. has a consensus price target of $136.11, signalling upside risk potential of 6.85%. On the other hand GeneDx Holdings Corp. has an analysts' consensus of $148.89 which suggests that it could grow by 124.91%. Given that GeneDx Holdings Corp. has higher upside potential than Illumina, Inc., analysts believe GeneDx Holdings Corp. is more attractive than Illumina, Inc..

Illumina, Inc. has a beta of 1.490, which suggesting that the stock is 49.007% more volatile than S&P 500. In comparison GeneDx Holdings Corp. has a beta of 2.173, suggesting its more volatile than the S&P 500 by 117.333%.

Illumina, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GeneDx Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Illumina, Inc. pays -- of its earnings as a dividend. GeneDx Holdings Corp. pays out -- of its earnings as a dividend.

Illumina, Inc. quarterly revenues are $1.2B, which are larger than GeneDx Holdings Corp. quarterly revenues of $121M. Illumina, Inc.'s net income of $334M is higher than GeneDx Holdings Corp.'s net income of -$17.7M. Notably, Illumina, Inc.'s price-to-earnings ratio is 23.31x while GeneDx Holdings Corp.'s PE ratio is 1,444.11x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina, Inc. is 4.58x versus 4.53x for GeneDx Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.